Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

206.70 +8.18 (+4.12%)
Streaming Delayed Price Updated: 3:21 PM EDT, Jul 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
IQVIA (IQV) Q1 2026 Earnings Call Transcript ↗
IQVIA (IQV) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
Which S&P500 stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
IQVIA (NYSE:IQV) Beats Q1 Estimates and Raises Guidance Despite Pre-Market Dip ↗
Via Chartmill
News headline image
IQVIA’s (NYSE:IQV) Q1 CY2026 Sales Top Estimates
Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 8.4% year on year to $4.15 billi... 
Via StockStory
Get insights into the top movers in the S&P500 index of Thursday's pre-market session. ↗
Via Chartmill
News headline image
IQVIA Reports First-Quarter 2026 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Veeva Systems Just Joined the S&P 500. 3 Reasons to Buy It and 1 Not To. ↗
Veeva Systems sits at the intersection of life sciences and enterprise cloud computing. 
Via The Motley Fool
Topics Stocks
News headline image
IQVIA (IQV) Reports Earnings Tomorrow: What To Expect
Clinical research company IQVIA (NYSE: IQV) will be reporting results this Tuesday before the bell. Here’s what you need to know. IQVIA beat analysts’ revenu... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de... 
Via StockStory
News headline image
Why Eli Lilly Stock Flopped on Friday ↗
High hopes for a freshly approved drug might not be realized, if early data is any indication. 
Via The Motley Fool
These S&P500 stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
From IQVIA
Via Business Wire
News headline image
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Reflecting On Drug Development Inputs & Services Stocks’ Q4 Earnings: IQVIA (NYSE:IQV)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory
News headline image
3 Profitable Stocks with Questionable Fundamentals
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
3 Value Stocks We Steer Clear Of
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
News headline image
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
From IQVIA Holdings Inc.
Via Business Wire
News headline image
1 S&P 500 Stock Worth Your Attention and 2 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
Veeva Systems (VEEV) Surges 11%: Navigating the Vault CRM Migration and the Future of Life Sciences Software
On March 5, 2026, Veeva Systems Inc. (NYSE: VEEV) reminded the market why it remains the undisputed heavyweight of life sciences software. Following a blockbuster Q4 fiscal year 2026 earnings report... 
Via Finterra
Topics Artificial Intelligence Economy
News headline image
Veeva Systems Q4 FY2026 Results: Dominating the 'Sensitive' Tech Frontier
As the sun sets on the final quarter of the 2026 fiscal year, Veeva Systems (NYSE: VEEV) has once again proven its mettle in the volatile world of vertical software. Reporting its Q4 results on March... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference
From IQVIA
Via Business Wire
News headline image
IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Releases its 2025 Sustainability Report
From IQVIA
Via Business Wire
News headline image
3 Reasons to Sell IQV and 1 Stock to Buy Instead
Over the last six months, IQVIA’s shares have sunk to $163.04, producing a disappointing 13.2% loss - a stark contrast to the S&P 500’s 6.5% gain. This may have investors wondering how to approach the... 
Via StockStory
Topics Stocks
News headline image
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
From IQVIA
Via Business Wire
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.